These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22344624)

  • 1. Acute treatment with candesartan cilexetil, an angiotensin II type 1 receptor blocker, improves insulin sensitivity in high-fructose-diet-fed rats.
    Li P; Koike T; Jiang HY; Wang ZH; Kawata Y; Oshida Y
    Horm Metab Res; 2012 Apr; 44(4):286-90. PubMed ID: 22344624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin II AT1 receptor inhibition and exercise training on insulin action in rats on high-fat diet.
    Wang Z; Koike T; Li P; Jiang H; Natsume Y; Mu L; Chen T; Oshida Y
    Life Sci; 2012 Feb; 90(9-10):322-7. PubMed ID: 22210187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet.
    Qin B; Nagasaki M; Ren M; Bajotto G; Oshida Y; Sato Y
    Horm Metab Res; 2004 Feb; 36(2):119-25. PubMed ID: 15002064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of angiotensin II type 1 receptor blocker on islet of diabetic db/db mice].
    Shao JQ; Iwashita N; Du H; Wang YY; Zhao M; Wang J; Watada H; Kawamori R
    Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):306-10. PubMed ID: 17637271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice.
    Shao J; Iwashita N; Ikeda F; Ogihara T; Uchida T; Shimizu T; Uchino H; Hirose T; Kawamori R; Watada H
    Biochem Biophys Res Commun; 2006 Jun; 344(4):1224-33. PubMed ID: 16650382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated application of low-frequency electroacupuncture improves high-fructose diet-induced insulin resistance in rats.
    Tominaga A; Ishizaki N; Naruse Y; Kitakoji H; Yamamura Y
    Acupunct Med; 2011 Dec; 29(4):276-83. PubMed ID: 21697213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion of beta-endorphin improves insulin resistance in fructose-fed rats.
    Su CF; Chang YY; Pai HH; Liu IM; Lo CY; Cheng JT
    Horm Metab Res; 2004 Aug; 36(8):571-7. PubMed ID: 15326568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation.
    Iwai M; Chen R; Imura Y; Horiuchi M
    Am J Hypertens; 2007 May; 20(5):579-86. PubMed ID: 17485025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Candesartan improves insulin resistance induced by high-fat diet in rats].
    Yan WH; Dou JT; Pan CY; Chen K; Wang XM; Ma FL; Yang GQ; Wang XL; Mu YM; Lu JM
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2695-9. PubMed ID: 19080690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats.
    Liu IM; Tzeng TF; Liou SS; Lan TW
    Life Sci; 2007 Nov; 81(21-22):1479-88. PubMed ID: 17976658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-fructose diet impairs Akt and PKCzeta phosphorylation and GLUT4 translocation in rat skeletal muscle.
    Li P; Koike T; Qin B; Kubota M; Kawata Y; Jia YJ; Oshida Y
    Horm Metab Res; 2008 Aug; 40(8):528-32. PubMed ID: 18500676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
    Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candesartan: widening indications for this angiotensin II receptor blocker?
    Mendis B; Page SR
    Expert Opin Pharmacother; 2009 Aug; 10(12):1995-2007. PubMed ID: 19563275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
    Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
    Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproteinuric effect of candesartan cilexetil in Japanese subjects with type 2 diabetes and nephropathy.
    Haneda M; Kikkawa R; Sakai H; Kawamori R;
    Diabetes Res Clin Pract; 2004 Oct; 66(1):87-95. PubMed ID: 15364166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an angiotensin II receptor antagonist, TCV-116, on insulin sensitivity in fructose-fed rats.
    Shimamoto K; Matsuda K; Takizawa H; Higashiura K; Ura N; Iimura O
    Blood Press Suppl; 1994; 5():113-6. PubMed ID: 7889192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats.
    Hashikawa-Hobara N; Hashikawa N; Inoue Y; Sanda H; Zamami Y; Takatori S; Kawasaki H
    Diabetes; 2012 Apr; 61(4):925-32. PubMed ID: 22357959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candesartan cilexetil effectively reduces blood pressure in hypertensive children.
    Franks AM; O'Brien CE; Stowe CD; Wells TG; Gardner SF
    Ann Pharmacother; 2008 Oct; 42(10):1388-95. PubMed ID: 18664605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.